EUVIMEDEUVIMED entdecken
Crossref

Clinical Characteristics of Sarcopenia Among SARC ‐F‐Negative Patients With Rheumatoid Arthritis

Mochihito Suzuki iD, Shuji Asai iD, Toshihisa Kojima iD, Hiroto Yamamoto iD, Yuki Saito iD, Yuma Saito iD, Kenya Terabe iD, Yoshifumi Ohashi, Kaoru Nagai, Chinami Ohnishi, Hideshi Sugiura, Hitomi Fujita iD und 3 weitere

Geriatrics & Gerontology International · 2026-11 · 26 (11)

DOI: 10.1111/ggi.70918 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Geriatrics & Gerontology International, online erschienen am 15.11.2026. Verfasst von Mochihito Suzuki und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Sarcopenia, Arthritis, Rheumatoid. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Aichi Health Promotion Foundation, Japan Society for the Promotion of Science, Japan Health Research Promotion Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenia is clinically important in patients with rheumatoid arthritis (RA) because chronic inflammation and physical dysfunction may contribute to muscle impairment. Although SARC‐F is widely used as a screening tool for sarcopenia, its diagnostic performance in patients with RA remains unclear. This study investigated the agreement between SARC‐F and Asian Working Group for Sarcopenia 2025 (AWGS2025)‐defined sarcopenia and evaluated clinical characteristics of sarcopenia in SARC‐F‐negative patients with RA.

Methods

This cross‐sectional study included 212 patients with RA enrolled in a prospective cohort. Sarcopenia was diagnosed according to the AWGS2025 criteria. Agreement between SARC‐F and AWGS2025‐defined sarcopenia was assessed using sensitivity, specificity, overall agreement, and Cohen's kappa coefficient. Multivariable logistic regression and receiver operating characteristic (ROC) curve analyses were performed for SARC‐F‐negative patients.

Results

The prevalence of SARC‐F positivity was 10.8%, whereas AWGS2025‐defined sarcopenia was observed in 25.0% of patients. Overall agreement between SARC‐F and AWGS2025‐defined sarcopenia was 72.6%, and Cohen's kappa coefficient was 0.10. Among SARC‐F‐negative patients, 23.3% had sarcopenia. Multivariable logistic regression analysis demonstrated that age and Health Assessment Questionnaire‐Disability Index (HAQ‐DI) were independently associated with sarcopenia. ROC analysis identified an optimal HAQ‐DI cutoff value of 0.25. Patients with sarcopenia showed lower walking speed and prolonged Timed Up and Go performance, despite negative SARC‐F results.

Conclusions

Among SARC‐F‐negative patients with RA, a substantial proportion met the AWGS2025 diagnostic criteria for sarcopenia and showed impaired physical performance. These findings indicate that a negative SARC‐F case‐finding result does not necessarily preclude sarcopenia diagnosed according to the AWGS2025 criteria. Trial Registration UMIN Clinical Trials Registry: UMIN000041034

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaArthritis, RheumatoidHumansFemaleMaleCross-Sectional StudiesAgedProspective StudiesMiddle AgedPrevalenceROC Curve

Stichwörter der Autor:innen

HAQ‐DISARC‐Fphysical performancerheumatoid arthritissarcopenia

Autor:innen und Institutionen

  • Department of Orthopedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Orthopedic Surgery, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan.
  • Department of Orthopedic Surgery, Aichi Medical University, Nagakute, Japan.
  • Nagoya Garden Clinic, Nagoya, Japan.
  • Kobayakawa Orthopedic & Rheumatologic Clinic, Shizuoka, Japan.
  • Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.

ORCID-Profile: Mochihito Suzuki, Shuji Asai, Toshihisa Kojima, Hiroto Yamamoto, Yuki Saito, Yuma Saito, Kenya Terabe, Hitomi Fujita, Masayo Kojima, Shiro Imagama

Förderung

  • Aichi Health Promotion Foundation
  • Japan Society for the Promotion of Science
  • Japan Health Research Promotion Bureau
  • Japan Agency for Medical Research and Development

Zitieren

APA

Suzuki, M., Asai, S., Kojima, T., Yamamoto, H., Saito, Y., Saito, Y., Terabe, K., Ohashi, Y., Nagai, K., Ohnishi, C., Sugiura, H., Fujita, H., Nagayoshi, M., Kojima, M., & Imagama, S. (2026). Clinical Characteristics of Sarcopenia Among SARC ‐F‐Negative Patients With Rheumatoid Arthritis. Geriatrics & Gerontology International, 26(11). https://doi.org/10.1111/ggi.70918

Vancouver

Suzuki M, Asai S, Kojima T, Yamamoto H, Saito Y, Saito Y, et al. Clinical Characteristics of Sarcopenia Among SARC ‐F‐Negative Patients With Rheumatoid Arthritis. Geriatrics & Gerontology International. 2026;26(11). doi:10.1111/ggi.70918

BibTeX
@article{Suzuki2026,
  author = {Suzuki, Mochihito and Asai, Shuji and Kojima, Toshihisa and Yamamoto, Hiroto and Saito, Yuki and Saito, Yuma and Terabe, Kenya and Ohashi, Yoshifumi and Nagai, Kaoru and Ohnishi, Chinami and Sugiura, Hideshi and Fujita, Hitomi and Nagayoshi, Mako and Kojima, Masayo and Imagama, Shiro},
  title = {Clinical Characteristics of Sarcopenia Among SARC ‐F‐Negative Patients With Rheumatoid Arthritis},
  journal = {Geriatrics & Gerontology International},
  year = {2026},
  volume = {26},
  number = {11},
  doi = {10.1111/ggi.70918}
}
Kostenlos starten →